Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 10,342 | 7,590 | 5,816 | 6,462 | 8,628 |
| Operating Income | -10,342 | -7,590 | -5,816 | -6,462 | -8,628 |
| Other Income | 65 | 685 | 290 | 399 | 342 |
| Pre-tax Income | -10,277 | -6,905 | -5,526 | -6,063 | -8,286 |
| Net Income Continuous | -10,277 | -6,905 | -5,526 | -6,063 | -8,286 |
| Net Income | $-10,277 | $-6,905 | $-5,526 | $-6,063 | $-8,286 |
| EPS Basic Total Ops | -86.39 | -57.59 | -46.80 | -52.19 | -70.19 |
| EPS Basic Continuous Ops | -86.29 | -58.43 | -47.02 | -51.59 | -70.61 |
| EPS Diluted Total Ops | -86.39 | -57.59 | -46.80 | -52.19 | -70.19 |
| EPS Diluted Continuous Ops | -86.29 | -58.43 | -47.02 | -51.59 | -70.61 |
| EBITDA(a) | $-10,277 | $-7,561 | $-5,782 | $-6,461 | $-8,632 |